Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Skin Neoplasms × Fluorouracil × Clear all

Phase

Phase 2 4 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 26 Pancreatic Neoplasms 23 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Stomach Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Adenocarcinoma Of Esophagus 6 Head and Neck Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Adenocarcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Kidney Neoplasms 2 Advanced Malignant Tumors 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1 Solid Neoplasms 1 Solid Cancer 1

Interventions

fludarabine 3 Cyclophosphamide 3 pembrolizumab 2 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 sargramostim 1 reolysin 1 poly ICLC 1 peginterferon alfa-2a 1 osimertinib 1 gusacitinib 1 fludarabine phosphate 1 eprenetapopt 1 dabrafenib 1 cobimetinib 1 cemiplimab 1 Vorinostat 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Poly I-C 1 Nivolumab 1 Monatide (IMS 3015) 1 Methods 1 MAPRE1 protein, human 1 Ipilimumab 1 Interleukin-15 1 Interleukin-12 1 Histone Deacetylase Inhibitors 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02550678 2018-06-06

ASN-002-001

Ascend Biopharmaceuticals Ltd

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡